University of Groningen has joined Pharma Connect Capital as a shareholder. The RUG Houdstermaatschappij, a department of the University of Groningen with the mission to support scientists in the process of starting a business, has made an investment in Pharma Connect Capital. This investment reflects the expectation of the RUG that several researchers at the RUG  have the ambition to start up pharma companies in the near future. It also reflects the vision of RUG that sharing forces with the current shareholders and management of Pharma Connect Capital is the best way to facilitate future pharma start up in the northern part of The Netherlands.  Management and current shareholders of Pharma Connect Capital very much welcome the support and participation of the University of Groningen.

More info:

← Griphingo and partners receive investment for innovative inhalation therapy Pharma Connect Capital invests in Sabiad →